Adjuvant Capecitabine in Triple Negative Breast Cancer Patients with Residual Disease after Neoadjuvant Treatment: Real-World Evidence from CaRe, a Multicentric, Observational Study.

Frontiers in oncology(2023)

引用 0|浏览60
暂无评分
关键词
triple negative breast cancer,neoadjuvant treatment,residual tumors,adjuvant capecitabine,treatment discontinuation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要